Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entresto in non-obstructive HCM
NCT04164732Phase 2Completed
- Sponsor
- Novartis
- Start
- Jan 2020
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of sacubitril + valsartan in hypertrophic cardiomyopathy (HCM), sponsored by Novartis. Started Jan 2020; status: completed.
02
Drugs
sacubitril + valsartan
03
Conditions
hypertrophic cardiomyopathy (HCM)
Beyond the preview
Go deeper on NCT04164732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04164732.